Johnson & Johnson (J&J) is set to acquire partner Auris Health for $3.4bn, with an additional $2.35bn available to the surgical robotics firm in predetermined milestone payments. The deal will see J&J become a major player in robotic surgery and The purchase is one of several forays the multinational has made in the surgical robotics sector, including last year's acquisition of Orthotaxy, and the creation of Verb Surgical, a joint venture with Alphabet's Verily.
Johnson & Johnson (J&J) is set to acquire partner Auris Health for $3.4bn, with an additional $2.35bn available to the surgical robotics firm in predetermined milestone payments. As part of the deal, surgical robotics pioneer and Auris founder Dr Fred Moll will join J&J. The purchase is one of several forays the multinational has made in the surgical robotics sector, including last year's acquisition of Orthotaxy, and the creation of Verb Surgical, a joint venture with Alphabet's Verily.